PTHS
Financials
- Market Capitalization 93.64 M
- Employee 92
- Founded 2002
- CEO N/A
- Website www.pelthos.com
- Headquarter Nevada, United States
- FIGI BBG01C9YP5V5
- Industry Drug Manufacturers—General
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3745 |  OKUR OnKure Therapeutics, Inc. - Class A Common Stock | 3.79 USD | -1.04% | -5.49% | -3.56% | +54.69% | 153.48 M USD | ||
| 3926 |  PLYX Polaryx Therapeutics, Inc. - Common Stock | 2.06 USD | -2.37% | -0.96% | +1.98% | -95.42% | 102.68 M USD | ||
| 3982 |  DWTX Dogwood Therapeutics, Inc. - Common Stock | 2.65 USD | +14.22% | +0.38% | +74.34% | -11.67% | 90.08 M USD | ||
| 4085 |  OSTX OS Therapies Incorporated Common Stock | 1.64 USD | -2.38% | +9.33% | +10.07% | +42.61% | 75.65 M USD |
Frequently asked questions about Pelthos Therapeutics Inc.
What is the Pelthos Therapeutics Inc. stock price today?
The current price of Pelthos Therapeutics Inc. (PTHS) is 24.46. Over the past 24 hours, the stock has changed by -2.28%. Follow the PTHS chart for real-time price dynamics.
What is the stock ticker of Pelthos Therapeutics Inc.?
Pelthos Therapeutics Inc. trades under the ticker PTHS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Pelthos Therapeutics Inc. stock going up?
PTHS has changed by -3.13% over the last week, -5.78% over the last month, and +3.78% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Pelthos Therapeutics Inc.?
Pelthos Therapeutics Inc. currently has a market capitalization of 93.64 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Pelthos Therapeutics Inc. earnings last quarter?
Last quarter, Pelthos Therapeutics Inc. reported earnings of -6.62 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Pelthos Therapeutics Inc. revenue for the last quarter?
Pelthos Therapeutics Inc. reported quarterly revenue of 15.6 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Pelthos Therapeutics Inc. net income for the last quarter?
Pelthos Therapeutics Inc. reported net income of -23.42 M for the last quarter. The previous quarter showed -10.24 M, which means net income changed by -128.73%.
How many employees does Pelthos Therapeutics Inc. have?
As of the latest available data, Pelthos Therapeutics Inc. has 92 employees. Workforce size can provide additional context about the company's scale and operations.
What is Pelthos Therapeutics Inc. EBITDA?
Pelthos Therapeutics Inc. EBITDA is -14.97 M, and its EBITDA margin is -95.95%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Pelthos Therapeutics Inc. stock?
You can buy Pelthos Therapeutics Inc. (PTHS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Pelthos Therapeutics Inc. stock?
Investing in Pelthos Therapeutics Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the PTHS chart and related analysis on metatrader.com as part of your research.